Slashdot videos: Now with more Slashdot!

View

Discuss

Share

We've improved Slashdot's video section; now you can view our video interviews, product close-ups and site visits with all the usual Slashdot options to comment, share, etc. No more walled garden! It's a work in progress -- we hope you'll check it out (Learn more about the recent updates).

sciencehabit writes Last week, researchers expanded the size of the mouse brain by giving rodents a piece of human DNA. Now another team has topped that feat, pinpointing a human gene that not only grows the mouse brain but also gives it the distinctive folds found in primate brains. The work suggests that scientists are finally beginning to unravel some of the evolutionary steps that boosted the cognitive powers of our species. "This study represents a major milestone in our understanding of the developmental emergence of human uniqueness," says Victor Borrell Franco, a neurobiologist at the Institute of Neurosciences in Alicante, Spain, who was not involved with the work.

An anonymous reader writes Deep learning is dominating the news these days, but it's quite possible the field could have died if not for a mysterious call that Geoff Hinton, now at Google, got one night in the 1980s: "You don't know me, but I know you," the mystery man said. "I work for the System Development Corporation. We want to fund long-range speculative research. We're particularly interested in research that either won't work or, if it does work, won't work for a long time. And I've been reading some of your papers." The Chronicle of Higher Ed has a readable profile of the minds behind neural nets, from Rosenblatt to Hassabis, told primarily through Hinton's career.

itamblyn writes In a surprising decision, Argonne National Laboratory has decided to pull the plug on its long-standing NEWTON Ask A Scientist Program. NEWTON is (soon to be was) an on online repository of science questions submitted by school children from around the world. A volunteer group of scientists contributed grade-level appropriate answers to these questions. For the past 25 years, a wide range of topics ranging have been covered, including the classic "why is the sky blue" to "is there way to break down the components of plastics completely into their original form". Over the years, over 20,000 questions have been answered. According to ANL, the website will be shut down permanently on 1 March. There is no plan to make the content available in an alternate form or to hand over stewardship to another organization. When contacted about transferring the repository to another institution or moving to a donation model, the response from ANL was simply: "Thank you again for all your support for Newton. Unfortunately, moving Newton to another organization is not a possibility at this time. Thank you again for your energy and support."

astroengine writes As NASA's Dawn mission slowly spirals in on its dwarf planet target, Ceres' alien landscape is becoming sharper by the day. And, at a distance of only 29,000 miles (46,000 kilometers), the robotic spacecraft has revealed multiple bright patches on the surface, but one of the brightest spots has revealed a dimmer bright patch right next door. "Ceres' bright spot can now be seen to have a companion of lesser brightness, but apparently in the same basin," said Chris Russell, of the University of California, Los Angeles (UCLA) and principal investigator for the Dawn mission. "This may be pointing to a volcano-like origin of the spots, but we will have to wait for better resolution before we can make such geologic interpretations."

HughPickens.com writes Every year at least two million people are infected with bacteria that can't be wiped out with antibiotics but the number of F.D.A.-approved antibiotics has decreased steadily in the past two decades. Now.Ezekiel J. Emanuel writes at the NYT that the problem with the development of new antibiotics is profitability. "There's no profit in it, and therefore the research has dried up, but meanwhile bacterial resistance has increased inexorably and there's still a lot of inappropriate use of antibiotics out there," says Ken Harvey. Unlike drugs for cholesterol or high blood pressure, or insulin for diabetes, which are taken every day for life, antibiotics tend to be given for a short time so profits have to be made on brief usage. "Even though antibiotics are lifesaving, they do not command a premium price in the marketplace," says Emanuel. "As a society we seem willing to pay $100,000 or more for cancer drugs that cure no one and at best add weeks or a few months to life. We are willing to pay tens of thousands of dollars for knee surgery that, at best, improves function but is not lifesaving. So why won't we pay $10,000 for a lifesaving antibiotic?"

Emanuel says that we need to use prize money as an incentive. "What if the United States government — maybe in cooperation with the European Union and Japan — offered a $2 billion prize to the first five companies or academic centers that develop and get regulatory approval for a new class of antibiotics?" Because it costs at least $1 billion to develop a new drug, the prize money could provide a 100 percent return — even before sales. "From the government perspective, such a prize would be highly efficient: no payment for research that fizzles. Researchers win only with an approved product. Even if they generated just one new antibiotic class per year, the $2-billion-per-year payment would be a reasonable investment for a problem that costs the health care system $20 billion per year." Unless payers and governments are willing to provide favorable pricing for such a drug, the big companies are going to focus their R&D investments in areas like cancer, depression, and heart disease where the return-on-investments are much higher.

schwit1 writes "Three Austrians have replaced injured hands with bionic ones that they can control using nerves and muscles transplanted into their arms from their legs. The three men are the first to undergo what doctors refer to as "bionic reconstruction," which includes a voluntary amputation, the transplantation of nerves and muscles and learning to use faint signals from them to command the hand. Previously, people with bionic hands have primarily controlled them with manual settings."

wombatmobile writes For more than 5,000 years, apiarists donned protective suits and lit bundles of grass to subdue swarms of angry bees while they robbed their hives of precious, golden honey. Now two Australian inventors have made harvesting honey as easy as turning a tap — literally. Cedar Anderson and his father Stuart have just been rewarded for a decades worth of inventing and refining with a $2 million overnight success on Indiegogo. Their Flow Hive coopts bees to produce honey in plastic cells that can be drained and restored by turning a handle, leaving the bees in situ and freeing apiarists from hours of smoke filled danger time every day.

An anonymous reader writes: We've come to a point where care robots are being used to assist people with illnesses and mobility problems. They can bring medicine, a glass of water, food, and other items that a person may have trouble getting to on their own. But what limits should we set on these robots? Should they be able to deliver alcoholic beverages? If so, should they refuse to serve them to certain people, like children or alcoholics? The issue is complicated further because these robots may have been purchased by the patient, by the doctor or hospital (which sent it home with the patient to monitor their health), or by a concerned family member who wants to monitor their relative. The latest poll research by the Open Roboethics Initiative looked at people's attitudes about whether a care robot should prioritize its owner's wishes over those of the patient.

StartsWithABang writes: One of the great, catastrophic truths of the Universe is that everything has an expiration date. And this includes every single point of light in the entire sky. The most massive stars will die in a spectacular supernova explosion when their final stage of core fuel runs out. At only an estimated 600 light years distant, Betelgeuse is one (along with Antares) of the closest red supergiants to us, and it's estimated to have only perhaps 100,000 years until it reaches the end of its life. Here's the story on what we can expect to see (and feel) on Earth when Betelgeuse explodes.

Dave Knott writes: Rats, long believed to be the scourge that brought the Black Death to 14th-century Europe, may not be the disease-bearing scoundrels we thought they were. Scientists have shifted blame for the medieval pandemic responsible for millions of deaths to a new furry menace: giant gerbils from Asia. University of Oslo researchers, working with Swiss government scientists, say a "pulse" of bubonic plague strains arrived sporadically from Asia. They posit the Yersinia pestis bacterium was likely carried over the Silk Road via fleas on the giant gerbils during intermittent warm spells. The fleas could have then transmitted the disease to humans. The Black Death is believed to have killed up to 200 million people in Europe. Though very rare today, cases of the plague still arise in Africa, Asia, the Americas and parts of the former Soviet Union, with the World Health Organization reporting 783 cases worldwide in 2013, including 126 deaths.

Mr D from 63 writes:
According to a report from the Associated Press, "For years, parents of babies who seem likely to develop a peanut allergy have gone to extremes to keep them away from peanut-based foods. Now a major study suggests that is exactly the wrong thing to do. Here's the published paper in the New England Journal of Medicine. It's interesting how this peanut allergy fear is a bit of a self-fulfilling prophecy. The situation involves a complete misconception of risk by many parents, and probably it doesn't stop at peanuts. Is there a bigger underlying problem here?

An anonymous reader writes: The NY Times has a pair of articles about a technology now being used in police investigations: computer generation of a suspect's face from only their DNA. Law enforcement in South Carolina had no pictures or descriptions of a man who murdered a mother and her daughter, but they had some of his DNA. From this, a company named Parabon NanoLabs used a technique called DNA phenotyping to create a rough portrait of the suspect's facial features, which the police then shared with the public.

The accuracy of these portraits is still an area of hot debate — most of them look rather generic. The NY Times staff tested it with a couple of their employees, circulating the DNA-inspired portraits and seeing if people could guess who it was supposed to be. None of the ~50 employees were able to identify reporter John Markoff, and only about 10 were able to identify video journalist Catherine Spangler. But even though the accuracy for a person's entire face is low, techniques for specific attributes, like eye color, have improved greatly. Of course, the whole situation raises a slew of civil liberties questions: "What traits are off limits? Should the authorities be able to test whether a suspect has a medical condition or is prone to violence should such testing be possible?"

n01 writes: Stuttering — a speech disorder in which sounds, syllables or words are repeated or prolonged — affects more than 70 million people, or about 1% of the population, worldwide. Once treated as a psychological or emotional condition, stuttering can now be traced to brain neuroanatomy and physiology. Two new studies from UC Santa Barbara researchers provide insight into the treatment of the speech disorder as well as understanding its physiological basis. The first paper, published in the American Journal of Speech-Language Pathology, finds that the MPI stuttering treatment program, a new treatment developed at UCSB, was twice as effective as the standard best practices protocol. The second study, which appears in the Journal of Speech, Language, and Hearing Research, uses diffusion spectrum imaging (DSI) in an MRI scanner to identify abnormal areas of white matter in the brains of adult stutterers. According to co-author Janis Ingham, a professor emerita of speech and hearing sciences at UCSB and co-author of both papers, the two studies taken together demonstrate two critical points: A neuroanatomic abnormality exists in the brains of people who stutter, yet they can learn to speak fluently in spite of it.

An anonymous reader writes Using a CT scanner, scientists and hospital staff at the Meander Medical Center in the Netherlands have discovered the mummified body of a Chinese monk inside a statue of Buddha. The monk is believed to have lived around the year 1100. From the article: "Glowing through the statue's golden cast, the human skeleton is believed to belong to Buddhist master Liu Quan, a member of the Chinese Meditation School. To further investigate the mummy, the researchers took the statue to the Meander Medical Center in Amersfoort and carried out an endoscopy and additional CT scans. They found out that Liu Quan's internal organs had been removed and replaced with scripts covered in Chinese writing. The museum speculates Liu Quan may have 'self-mummified' in order to become a 'living Buddha.'

schwit1 writes Compared to other recreational drugs — including alcohol — marijuana may be even safer than previously thought. And researchers may be systematically underestimating risks associated with alcohol use. They found that at the level of individual use, alcohol was the deadliest substance (abstract), followed by heroin and cocaine.

merbs writes When we feel sick, fear disease, or have questions about our health, we turn first to the internet. According to the Pew Internet Project, 72 percent of US internet users look up health-related information online. But an astonishing number of the pages we visit to learn about private health concerns—confidentially, we assume—are tracking our queries, sending the sensitive data to third party corporations, even shipping the information directly to the same brokers who monitor our credit scores.

An anonymous reader writes Two competing teams for the Google Lunar XPrize have announced that they are partnering for a mission to the moon in the second half of 2016. From the article: "The Google Lunar XPrize , a $30 million purse of prizes encouraging private teams to put lunar rovers on the moon, this morning took if not quite a giant leap, then at least a big step. Two of those teams, Pittsburgh-based Astrobotic and Japan-based Hakuto, signed on to share a rocket ride to the moon in late 2016. Hakuto, which developed a pair of rovers to explore the lunar surface, will hitch a ride on Astrobotic's lander, which plans to set down in Lacus Mortis, located in the northeastern portion of the moon. Once on the surface, both teams will deploy their rovers and go exploring. The first to cover 500 meters (around 550 yards) while broadcasting high-definition footage will take home the $20 million grand prize."

Probably -- if the device I want supports itProbably -- if it works as promisedProbably -- credit cards will be like checks in another decadeNot sure -- no strong opinions either wayDoubtful -- not a useful technology to meDoubtful -- it will be too fragmentedDoubtful -- privacy/security concernsDoes throwing my spare change at the cashier count as mobile?